In vitro, LAP@ZIF-8 exhibited potent, selective cytotoxicitytoward HER2-positive SK-BR-3 breast-cancer cells (72 h IC50 = 1.2 μg mL–1) while sparing HER2-negativeMCF-7 cells. This evidence concerns the gene ERBB2 and breast carcinoma.